World Bladder Cancer Patient Coalition

Tweet this page
<
2020
2021
2022
2023
>
Registration as it was on 20 Nov 2023
How to read and use this data card.
Download this datacard

Overview

Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

Lobbying Costs

None declared

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

0.2 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    World Bladder Cancer Patient Coalition   (WBCPC)

    EU Transparency Register

    337323338117-73 First registered on 11 May 2020

    Goals / Remit

    Our mission is to improve the lives of those affected by bladder cancer globally and to foster cooperation among bladder cancer organizations globally and with all related and appropriate organizations.

    The World Bladder Cancer Patient Coalition seeks to foster an international community of people affected by bladder cancer; Advocate for access to the best bladder cancer information, support and care; Build alliances with health professionals, policy makers, academics, researchers & industry

    Main EU files targeted

    The World Bladder Cancer Patient Coalition follows all policies and legislative files, as well as initiatives, on all aspects related to cancer and health. This also includes research & development in health, digital health, data privacy, pharmaceutical development, cross-border healthcare.

    Some key legislative files include:

    -Europe’s Beating Cancer Plan
    -Health Technology Assessment
    -Horizon Europe Cancer Mission

    Address

    Head Office
    Square de Meeûs 38-40
    Brussels 1000
    BELGIUM
    EU Office
    Square de Meeûs 38-40
    Brussels 1000
    BELGIUM

    Website

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    10%2

    Lobbyists (Full time equivalent)

    0.2

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    All.Can International
    WECAN
    European Health Policy Forum
    EFPIA Patient Think Tank
    European Cancer Organisation Patient Advisory Committee
    Global Cancer Coalitions Network
    UICC

    https://worldbladdercancer.org/network/

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Does not represent commercial interests

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

    Total organisational budget in closed year

    481,370€

    Major funding types in closed year

    Other, Grants

    Funding types "other" information

    Major contributions in closed year

    TypeNameAmount
    Contribution AstraZeneca 30,000€
    Contribution Astellas Pharma 67,000€
    Contribution Bristol Myers Squibb 65,000€
    Contribution Janssen 25,000€
    Contribution MSD 25,000€
    Contribution Merck KGaA 50,000€
    Contribution Pfizer 50,000€
    Contribution Roche 45,000€
    Contribution Seagen 32,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    N/A

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard